Development of SARS-CoV-2 replicons for the ancestral virus and variant of concern Delta for antiviral screening (2022)

First Author: Erdmann M

Attributed to: The production and application of SARS-CoV-2 reverse genetic systems to facilitate vaccine development and biosafe drug discovery platforms. funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2022.10.11.511804

Publication URI: http://dx.doi.org/10.1101/2022.10.11.511804

Type: Preprint